|
|
|
|
| LEADER |
02951nam a22003615i 4500 |
| 001 |
000281585 |
| 005 |
20211102145412.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2008 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387789521
|
| 024 |
7 |
|
|a 10.1007/978-0-387-78952-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Current Topics in Complement II /
|c edited by John D. Lambris.
|
| 250 |
|
|
|a 1st ed. 2008.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2008.
|
| 300 |
|
|
|a XXX, 307 p. 65 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 632
|
| 505 |
0 |
|
|a Adipokines and the Immune System: An Adipocentric View -- The Role of Complement in Stroke Therapy -- Food Intake Regulation by Central Complement System -- A Pivotal Role of Activation of Complement Cascade (CC) in Mobilization of Hematopoietic Stem/Progenitor Cells (HSPC) -- Regulation of Tissue Inflammation by Thrombin-Activatable Carboxypeptidase B (or TAFI) -- Interaction Between the Coagulation and Complement System -- Platelet Mediated Complement Activation -- Adrenergic Regulation of Complement-Induced Acute Lung Injury -- Ficolins: Structure, Function and Associated Diseases -- Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms -- Role of Complement in Motor Neuron Disease: Animal Models and Therapeutic Potential of Complement Inhibitors -- The Role of Membrane Complement Regulatory Proteins in Cancer Immunotherapy -- Role of Complement in Ethanol-Induced Liver Injury -- Immune Complex-Mediated Cytokine Production is Regulated by Classical Complement Activation both In Vivo and In Vitro -- Subversion of Innate Immunity by Periodontopathic Bacteria via Exploitation of Complement Receptor-3 -- Staphylococcal Complement Inhibitors: Biological Functions, Recognition of Complement Components, and Potential Therapeutic Implications -- Human Astrovirus Coat Protein: A Novel C1 Inhibitor -- Hypothesis: Combined Inhibition of Complement and CD14 as Treatment Regimen to Attenuate the Inflammatory Response -- Targeting Classical Complement Pathway to Treat Complement Mediated Autoimmune Diseases -- Compstatin: A Complement Inhibitor on its Way to Clinical Application -- Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
0 |
|a Infectious diseases.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
1 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Microbiology.
|
| 650 |
2 |
4 |
|a Infectious Diseases.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 700 |
1 |
|
|a Lambris, John D.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|